Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1859423Generated: November 1, 2026

(r)-5,11-Dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl] dibenzo[b,e][1,4]oxazepine → (r)-5,11-Dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl] dibenzo[b,e][1,4] oxazepine hydrochloride

https://huagongshe.com/reaction/1859423

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(r)-5,11-Dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl] dibenzo[b,e][1,4]oxazepineHCID 15520941—
Reactant1,4-Dioxane hydrochlorideHCID 20443148—
SolventDichloromethaneHCID 6344—
Product(r)-5,11-Dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl] dibenzo[b,e][1,4] oxazepine hydrochlorideHCID 22975054—

Reaction Steps

3.0 ml of 4 M hydrochloric acid/dioxane was added to a solution of (R)-5,11-dihydro-5-[1-(4-methoxyphenethyl)piperidine-2-ylmethyl] dibenzo[b,e][1,4]oxazepine (0.63 g) in dichloromethane (10 ml), and they were stirred for 2 hours. The solvent was evaporated under reduced pressure. The obtained residue was recrystallized from a mixed solvent of acetone and ether to obtain the title compound in the form of a white solid (496 mg, 73%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06528504B2
Source datasetuspto-grants-2003_03
ORD IDord-a1c5a4c9a3bd412c829a6b137d83a879
Source noteuspto-grants-2003_03